MDXHNasdaqServices-Medical Laboratories

MDxHealth SA

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 3, 2026

$0.18−0.02 (-11.33%)

Close on Oct 19, 2026

Market cap: –
P/E (TTM): –
Dividend yield: –

MDxHealth SA income statement

AnnualQuarterlyTTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31
Revenue	108	90	70	37	22	18	12
Cost of Revenue	38	35	26	18	12	10	12
Gross Profit	70	55	44	19	11	8.04	0.03
Research & Development	10	11	6.38	5.50	5.59	4.54	9.00
Selling, General & Admin	–	–	–	29	–	–	–
Selling & Marketing	43	41	37	26	17	17	18
General & Administrative	–	–	–	3.70	–	–	–
Operating Expenses	–	–	0.08	0.07	0.04	0.04	2,505
Operating Income	-14	-25	-27	-38	-27	-27	-43
Interest Expense	23	15	18	6.39	2.17	1.54	0.52
Interest & Investment Income	2.06	2.36	2.57	0.24	0.01	0.00	0.01
Pretax Income	-35	-38	-43	-44	-29	-29	-44
Income Tax Expense	-1.86	0.38	0.00	0	0	0	-0.58
Net Income incl. Noncontrolling Interests	-34	-38	-43	-44	-29	-29	-43
Net Income	-34	-38	-43	-44	-29	-29	-43
EPS (Basic)(per share)	-0.67	-1.16	-1.66	-2.78	-2.38	-3.40	-6.90
EPS (Diluted)(per share)	-0.67	-1.16	-1.66	-2.78	2.38	3.40	-6.90
Shares Outstanding (Basic, Weighted)(shares)	50	33	26	16	12	8.32	0.23
Shares Outstanding (Diluted, Weighted)(shares)	50	33	26	16	12	8.32	0.23
EBITDA	–	–	-25	-36	-25	-24	-40

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Dec 31, 2025

Profitability, FY2025

Gross margin: 64.5%
Operating margin: -13.4%
Net margin: -31.1%
Return on equity, FY2025: –

Financial strength

Current ratio: 1.08
Debt to equity: –
Debt to assets: 51.5%
Cash to current liabilities: 58.6%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –